VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.50K | 24.60K | 23.60K | 40.90K | 45.50K |
| Total Receivables | -- | -- | -- | 60.00K | 130.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.70K | 39.70K | -- | 5.40K | 12.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 45.30K | 64.30K | 23.60K | 106.30K | 188.10K |
|
|
|||||
| Total Current Assets | 45.30K | 64.30K | 23.60K | 106.30K | 188.10K |
| Net Property, Plant & Equipment | 19.10K | 67.00K | 113.70K | 171.00K | 216.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 64.30K | 131.30K | 137.30K | 277.30K | 404.90K |
|
|
|||||
| Total Accounts Payable | 2.78M | 2.69M | 2.75M | 2.73M | 2.62M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 47.20K | 93.30K | 138.30K | 182.10K |
| Total Finance Division Other Current Liabilities | 992.20K | 919.80K | 644.20K | 577.60K | 577.60K |
| Total Other Current Liabilities | 992.20K | 919.80K | 644.20K | 577.60K | 577.60K |
| Total Current Liabilities | 3.77M | 3.66M | 3.49M | 3.44M | 3.38M |
|
|
|||||
| Total Current Liabilities | 3.77M | 3.66M | 3.49M | 3.44M | 3.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.77M | 3.66M | 3.49M | 3.44M | 3.38M |
|
|
|||||
| Common Stock & APIC | 1.24M | 1.20M | 1.16M | 1.12M | 1.07M |
| Retained Earnings | -4.94M | -4.72M | -4.51M | -4.28M | -4.05M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -3.70M | -3.53M | -3.35M | -3.17M | -2.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.70M | -3.53M | -3.35M | -3.17M | -2.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.70M | -3.53M | -3.35M | -3.17M | -2.97M |
|
|
|||||